(Q28743986)
Statements
Prolonged treatment with pimelic o-aminobenzamide HDAC inhibitors ameliorates the disease phenotype of a Friedreich ataxia mouse model (English)
0 references
June 2011
0 references
42
0 references
3
0 references
496-505
0 references
1 reference
1 reference
1 reference
1 reference
1 reference